The Food and Drug Administration(FDA) has approved three vaccines against infection by certain strains of human papillomavirus (HPV), the most common sexually transmitted infection in the United States. Initially, the vaccines were recommended only for girls and young women, but in 2011 the Centers for Disease Control and Prevention (CDC) broadened the recommendations to include boys and young men. This fact sheet discusses HPV and cancers related to the virus, such as cervical cancer, throat cancer and anal cancer. It also discusses use of the HPV vaccines for both females and males, and insurance coverage and access to the vaccines.
- state & global data
- view as grid
- view as list
The U.S. Government and International Family Planning & Reproductive Health: Statutory Requirements and Policies
This fact sheet summarizes the major statutory requirements and policies pertaining to U.S. global family planning/reproductive health (FP/RH) efforts over time and identifies those currently in effect. These laws and policies collectively serve to direct how U.S. funds are spent, to where and which organizations funds are provided, and generally shape the implementation and define the scope of U.S. global FP/RH activities. This fact sheet provides an update on the status of provisions examined in more depth in the 2012 Kaiser Family Foundation issue brief Statutory Requirements & Policies Governing U.S. Global Family Planning and Reproductive Health Efforts.
This brief analyzes state policies and insurer coverage decisions affecting the availability of abortion coverage in 2015 insurance plans offered through the Marketplaces. It finds that abortion coverage is unavailable in a total of 31 states, 24 of which have enacted laws that ban or restrict abortion coverage in plans sold through their Marketplaces and 7 of which have no abortion coverage restrictions but also have no Marketplace plans offering it.
This fact sheet reviews current national and state policies around Emergency Contraception, including methods, patient awareness, access and availability, and insurance coverage. Among methods discussed are ulipristal acetate (including ella), copper IUDs (including Copper-T IUDs), and progestin-based pills (including Plan B, Next Choice,Levonorgestrel and Fallback Solo).
This issue brief, Coverage of Abortion Services and the Affordable Care Act (ACA), summarizes the major coverage provisions of the ACA that are relevant for women of reproductive age, reviews current federal and state policies on Medicaid and insurance coverage of abortion services as they relate to the ACA, and presents national and state estimates on the availability of abortion coverage for women who are newly eligible for Medicaid or private coverage through the Marketplaces as a result of the ACA.
This short fact sheet answers questions about how where a woman works may affect the contraceptive coverage she may receive.
The Affordable Care Act (ACA) requires most private health insurance plans to provide coverage for a broad range of preventive services including FDA approved prescription contraceptives and services for women. Legal challenges and recently issued rules have affected contraceptive coverage for many women.
The Affordable Care Act’s requirement that most private health insurance plans provide contraceptive coverage has been the focus of ongoing litigation in the federal courts. In response to recent Supreme Court actions in the Hobby Lobby and College of Wheaton cases, the U.S. Department of Health and Human Services issued…
This fact sheet provides key data on sexual activity, contraceptive use, pregnancy, prevalence of Sexually Transmitted Infections (STIs), and access to reproductive health services among teenagers and young adults in the U.S.
This fact sheet examines the U.S. government’s role in international family planning and reproductive health worldwide, including the history of U.S. government involvement, current programs and funding, and key issues.